IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Regeneron Pharms Inc

CUSIP: 76886F107 | 1 institutional holders

Quarters

Q4 2019Q3 2019Q2 2019Q1 2019Q4 2018
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2019

Jacobs & Co7,043
0.0% of portfolio›$2.6K
StyleTurnoverLocationFiled
Jacobs & Co
7,043$2.6K0.0%GrowthLowSan Francisco, CA2020-01-29